{"id":476064,"date":"2024-05-01T10:12:21","date_gmt":"2024-05-01T08:12:21","guid":{"rendered":"https:\/\/innovationorigins.com\/?p=476064"},"modified":"2024-05-01T10:12:21","modified_gmt":"2024-05-01T08:12:21","slug":"vitestro-raises-e20-million-for-autonomous-blood-collection-device","status":"publish","type":"post","link":"https:\/\/ioplus.nl\/archive\/en\/vitestro-raises-e20-million-for-autonomous-blood-collection-device\/","title":{"rendered":"Vitestro raises \u20ac20 million for autonomous blood collection device"},"content":{"rendered":"\n<p>Vitestro has raised \u20ac20 million to accelerate the commercialization of their autonomous blood sampling device. The Dutch start-up announced this yesterday in a&nbsp;<a target=\"_blank\" href=\"https:\/\/vitestro.com\/vitestro-haalt-20-miljoen-euro-op-voor-autonomoom-bloedafnameapparaat\/\" rel=\"noreferrer noopener\">press release<\/a>. This round of funding brings the total fundraising to \u20ac46 million. With this capital injection, Vitestro will expand its team and develop additional features for the device.<\/p>\n\n\n\n<p>Vitestro&#8217;s technology has the potential to transform patient care and ease the burden on laboratory staff. Hospitals&nbsp;are expected&nbsp;to begin using the first blood collection devices by the end of this year.<\/p>\n\n\n\n<p>The funding is a significant milestone for Vitestro, founded in 2017 in Utrecht, Netherlands. The company has focused on improving patients&#8217; and clinicians&#8217; blood collection experience. Today&#8217;s healthcare market faces challenges such as staff shortages and increasing pressure on laboratory services. Vitestro&#8217;s innovative technology can play an essential role in addressing these issues.<em>&nbsp;<\/em><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Technological advances in the medical field<\/h2>\n\n\n\n<p>Vitestro&#8217;s autonomous blood sampling device uses artificial intelligence, ultrasound-guided imaging technology, and robotic needle insertion for accurate blood sampling. This advanced technology provides opportunities for a consistent and enhanced patient experience while relieving caregivers.<\/p>\n\n\n\n<p>The investors backing Vitestro, such as Sonder Capital, NYBC Ventures, and Invest-NL, are not just optimistic but confident about the company&#8217;s potential. With the infusion of new funds, Vitestro is poised to expand its team, cater to the increasing demand, and introduce innovative product features.<\/p>\n\n\n<div class=\"vlp-link-container vlp-layout-basic wp-block-visual-link-preview-link advgb-dyn-ab15dce0\"><a href=\"https:\/\/innovationorigins.com\/en\/skinives-ai-detects-skin-diseases-through-your-smartphone\/\" class=\"vlp-link\" title=\"Skinive\u2019s AI detects skin diseases through your smartphone\" rel=\"nofollow\" target=\"_blank\"><\/a><div class=\"vlp-layout-zone-side\"><div class=\"vlp-block-2 vlp-link-image\"><img decoding=\"async\" src=\"https:\/\/innovationorigins.com\/app\/uploads\/2024\/04\/skinive.png\" style=\"max-width: 150px; max-height: 150px\" \/><\/div><\/div><div class=\"vlp-layout-zone-main\"><div class=\"vlp-block-0 vlp-link-title\">Skinive\u2019s AI detects skin diseases through your smartphone<\/div><div class=\"vlp-block-1 vlp-link-summary\">Skinive\u2019s algorithm can detect up to fifty skin diseases simply by taking a picture with your smartphone.<\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Vitestro has raised \u20ac20 million to accelerate the commercialization of their autonomous blood sampling device. The Dutch start-up announced this yesterday in a&nbsp;press release. This round of funding brings the total fundraising to \u20ac46 million. With this capital injection, Vitestro will expand its team and develop additional features for the device. Vitestro&#8217;s technology has the [&hellip;]<\/p>\n","protected":false},"author":2589,"featured_media":506386,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[83907],"tags":[38801,28102,84341],"location":[6763],"article_type":[36684],"serie":[],"archives":[],"internal_archives":[],"reboot-archive":[82868],"class_list":["post-476064","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bio-en","tag-investment","tag-start-up-en","tag-vitestro","location-netherlands","article_type-news","reboot-archive-bio"],"blocksy_meta":[],"acf":{"subtitle":"Vitestro, which is developing the first fully autonomous blood collection device, has raised \u20ac20 million ($22 million).","text_display_homepage":false},"author_meta":{"display_name":"Team IO","author_link":"https:\/\/ioplus.nl\/archive\/author\/erikdevries\/"},"featured_img":"https:\/\/ioplus.nl\/archive\/wp-content\/uploads\/2024\/05\/vitestro.jpg","coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/bio-en\/\" class=\"advgb-post-tax-term\">BIO+<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">BIO+<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/bio-en\/\" class=\"advgb-post-tax-term\">investment<\/a>","<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/bio-en\/\" class=\"advgb-post-tax-term\">start-up<\/a>","<a href=\"https:\/\/ioplus.nl\/archive\/en\/category\/bio-en\/\" class=\"advgb-post-tax-term\">Vitestro<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">investment<\/span>","<span class=\"advgb-post-tax-term\">start-up<\/span>","<span class=\"advgb-post-tax-term\">Vitestro<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 2 years ago","modified":"Updated 2 years ago"},"absolute_dates":{"created":"Posted on May 1, 2024","modified":"Updated on May 1, 2024"},"absolute_dates_time":{"created":"Posted on May 1, 2024 10:12 am","modified":"Updated on May 1, 2024 10:12 am"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/posts\/476064","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/users\/2589"}],"replies":[{"embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/comments?post=476064"}],"version-history":[{"count":0,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/posts\/476064\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/media\/506386"}],"wp:attachment":[{"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/media?parent=476064"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/categories?post=476064"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/tags?post=476064"},{"taxonomy":"location","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/location?post=476064"},{"taxonomy":"article_type","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/article_type?post=476064"},{"taxonomy":"serie","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/serie?post=476064"},{"taxonomy":"archives","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/archives?post=476064"},{"taxonomy":"internal_archives","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/internal_archives?post=476064"},{"taxonomy":"reboot-archive","embeddable":true,"href":"https:\/\/ioplus.nl\/archive\/wp-json\/wp\/v2\/reboot-archive?post=476064"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}